Individual Response Monitoring Assay (IRMA) – Standardization of Personalized Multiplex Biomarker Quantification
Conference: MikroSystemTechnik 2019 - Kongress
10/28/2019 - 10/30/2019 at Berlin, Deutschland
Proceedings: MikroSystemTechnik Kongress 2019
Pages: 2Language: englishTyp: PDF
Personal VDE Members are entitled to a 10% discount on this title
Authors:
Juelg, Peter; Specht, Mara; Meyer, Martin; Schlenker, Franziska (Hahn-Schickard, Freiburg, Germany)
Kipf, Elena; von Stetten, Felix; Zengerle, Roland; Paust, Nils; Lehnert, Michael; Hutzenlaub, Tobias (Hahn-Schickard, Freiburg & Laboratory for MEMS Applications, IMTEK-Department of Microsystems Engineering, University of Freiburg, Germany)
Baensch, Felix; Neumann, Stefan (GNWI Gesellschaft für naturwissenschaftliche Informatik mbH, Germany)
Fillies, Marion; Kirschner-Schwabe, Renate; Groeneveld-Krentz, Stefanie; Eckert, Cornelia (Charité Universitätsmedizin Berlin, Germany)
Abstract:
The emerging demand for personalized cancer diagnostics is in conflict with an increasing challenge for assay standardization by regulatory authorities. Minimal residual disease (MRD) monitoring of acute lymphoblastic leukemia (ALL) patients is such an assay [1]. Here, patient-individual primer designs and PCR optimizations make assay standardization challenging. The IRMA approach combines three technological advances to provide a solution for standardized and patient-individual PCR assays: (1) Software assisted assay design (2) Modular assay technology (3) Microfluidic standardization.